GlassScriptPhysician profile
Ruthanna R Hunter
NPI 1821228404
$2,969.59
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $1,114 · 2021: $123 · 2023: $74.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $439.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $395.67 | 2019-2020 | |
| Allergan, INC. | $247.75 | 2020 | |
| Supernus Pharmaceuticals, INC. | $223.57 | 2019-2020 | |
| Genzyme Corporation | $188.97 | 2019-2020 | |
| Eisai INC. | $175.96 | 2019-2020 | |
| Abbott Laboratories | $142.49 | 2020-2023 | Infinity |
| Abbvie INC. | $121.54 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $88.11 | 2019-2020 | |
| Emd Serono, INC. | $68.41 | 2020 | |
| Amgen INC. | $66.85 | 2019-2020 | |
| Saol Therapeutics INC. | $60.00 | 2020 | |
| Sunovion Pharmaceuticals INC. | $51.55 | 2020 | |
| Lilly USA, LLC | $50.28 | 2019 | |
| Grifols USA, LLC | $42.88 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruthanna Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.